Evidence map›Paper›PMID 40650706›Full record

ArticleJournal of molecular modeling2025

Separation mechanism and chiral-HPLC chromatogram profile of racemic mandelate compounds: a comparative study between experiment and computation using conformer-rotamer ensemble sampling tool (CREST)-XTB.

Fenti Fatmawati, Aditya Wibawa Sakti, Suci Zulaikha Hildayani, Akhmaloka, Fida Madayanti Warganegara, Muhamad Abdulkadir Martoprawiro

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Journal of molecular modeling, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Fenti FatmawatiDoctoral Program of Chemistry, Faculty of Mathematics and Natural Science, Institut Teknologi Bandung, Bandung, Indonesia.
Aditya Wibawa SaktiGlobal Center for Science and Engineering, Waseda University, Shinjuku, 169-8555, Japan.
Suci Zulaikha HildayaniResearch Center for Computing, National Research and Innovation Agency (BRIN), Cibinong, Indonesia.
AkhmalokaBiochemistry Research Group, Faculty of Mathematics and Natural Science, Institut Teknologi Bandung, Bandung, Indonesia.
Fida Madayanti WarganegaraBiochemistry Research Group, Faculty of Mathematics and Natural Science, Institut Teknologi Bandung, Bandung, Indonesia.
Muhamad Abdulkadir MartoprawiroInorganic and Physical Chemistry Research Group, Faculty of Mathematics and Natural Sciences, Institut Teknologi Bandung, Bandung, Indonesia. muhamad@itb.ac.id.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

contextNearly 90% of drugs on the market are racemates. A racemate is a mixture of two enantiomers or substances in equal amounts that have an asymmetric molecular structure that is a mirror image of each other. Despite having the same chemical structure, chiral drug isomers can exhibit very different biological behaviors in terms of pharmacology, toxicity, pharmacokinetics, metabolism, etc. Since racemic drugs have only one bioactive enantiomer while its counterpart enantiomers impart undesirable pharmacological properties, it is necessary to separate these racemic compounds to obtain the desired active enantiomer. Chromatography is one of the approaches for the separation of enantiomers. In this study, we observed the chromatographic profile of racemic mandelic acid compound passed through a chiral HPLC column. The chromatogram profile was then observed computationally to study the separation mechanism. The experimental results are in line with the computational analysis that the S chromatogram eluted first compared to the R-enantiomer. It can be predicted that the binding energy of the R-enantiomer (-108.92 kJ/mol) is stronger than the S-enantiomer (- 67 kJ/mol).

methodsThe chromatogram profile of mandelic acid racemate was observed experimentally using a chiral OD column, and the prediction of column-ligand binding energy was based on computational studies using the conformer-rotamer ensemble sampling tool (CREST). The chromatogram profile was identified using a 0.46 cm × 25 cm chiral OD column HPLC instrument (Daicel Chemical). The samples used were racemic compounds of mandelic acid and standard (S)-mandelic acid. Computational calculations of column capacity factors and binding energies of each enantiomer were performed with a Windows 11 Pro 64-bit operating system, × 64-based processor, equipped with the MGL-Tools program consisting of the ADT (Autodock Tools) application, Avogadro, AutoDock 4.2, Discovery Studio 2020 Client®, and CREST installed as a driver program for the XTB semiempirical quantum chemistry package. For geometry optimization and sampling of DMPC-ligand complexes, we used CREST at https://github.com/grimme-lab/crest .

Indexed as

Mandelic AcidsChromatography, High Pressure LiquidMolecular ConformationStereoisomerismmandelic acidMandelic AcidsChromatogramCREST XTBEnantiomerHPLCRacemate

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.